Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 95,177 | 73,178 | 42,223 | 43,994 | 28,367 |
| Marketable Securities | 291,408 | 136,906 | 172,247 | 205,238 | 224,921 |
| Receivables | 44,809 | 46,569 | 51,288 | 49,036 | 48,207 |
| TOTAL | $448,465 | $271,137 | $283,704 | $311,713 | $313,035 |
| Non-Current Assets | |||||
| PPE Net | 12,014 | 11,050 | 8,682 | 6,173 | 4,588 |
| Investments And Advances | 5,924 | 15,040 | 26,939 | 29,285 | 39,427 |
| Other Non-Current Assets | 28,766 | 29,218 | 28,209 | 28,239 | 28,164 |
| TOTAL | $46,704 | $55,308 | $63,830 | $63,697 | $72,179 |
| Total Assets | $495,169 | $326,445 | $347,534 | $375,410 | $385,214 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,932 | 11,761 | 4,352 | 6,000 | 1,245 |
| Accrued Expenses | 18,196 | 15,482 | 15,163 | 20,936 | 19,191 |
| Other current liabilities | 36,693 | N/A | N/A | N/A | N/A |
| TOTAL | $68,189 | $32,166 | $23,001 | $29,827 | $23,035 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 189,161 | 24,904 | 23,696 | 24,249 | 24,156 |
| TOTAL | $189,161 | $24,904 | $23,696 | $24,249 | $24,156 |
| Total Liabilities | $257,350 | $57,070 | $46,697 | $54,076 | $47,191 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,055 | 21,055 | 20,886 | 20,797 | 20,725 |
| Common Shares | 210 | 210 | 209 | 208 | 207 |
| Retained earnings | -178,888 | -139,823 | -102,165 | -73,179 | -46,831 |
| Other shareholders' equity | -1,504 | -1,815 | -2,675 | -3,724 | -3,620 |
| TOTAL | $237,819 | $269,375 | $300,837 | $321,334 | $338,023 |
| Total Liabilities And Equity | $495,169 | $326,445 | $347,534 | $375,410 | $385,214 |